Expression status of folate receptor alpha is a predictor of survival in pancreatic ductal adenocarcinoma

Por Cai, Lei, Michelakos, Theodoros, Ferrone, Cristina R., Zhang, Liyuan, Deshpande, Vikram, Shen, Qi, DeLeo, Albert, Yamada, Teppei, Zhang, Gong, Ferrone, Soldano, Wang, Xinhui
Publicado no Oncotarget (2017)

Obesity-induced inflammation and desmoplasia promote pancreatic cancer progression and resistance to chemotherapy

Por Incio, Joao, Liu, Hao, Suboj, Priya, Chin, Shan M., Chen, Ivy X., Pinter, Matthias, Ng, Mei R., Nia, Hadi T., Grahovac, Jelena, Kao, Shannon, Babykutty, Suboj, Huang, Yuhui, Jung, Keehoon, Rahbari, Nuh N., Han, Xiaoxing, Chauhan, Vikash P., Martin, John D., Kahn, Julia, Huang, Peigen, Desphande, Vikram, Michaelson, James, Michelakos, Theodoros P., Ferrone, Cristina R., Soares, Raquel, Boucher, Yves, Fukumura, Dai, Jain, Rakesh K.
Publicado no Cancer Discov (2016)

Use of Angiotensin System Inhibitors is Associated with Immune Activation and Longer Survival in Non-Metastatic Pancreatic Ductal Adenocarcinoma

Por Liu, Hao, Naxerova, Kamila, Pinter, Matthias, Incio, Joao, Lee, Hang, Shigeta, Kohei, Ho, William, Crain, Jonathan, Jacobson, Alex, Michelakos, Theodoros, Dias-Santos, Daniella, Zanconato, Andrea, Hong, Theodore S, Clark, Jeffrey W, Murphy, Janet E, Ryan, David P, Deshpande, Vikram, Lillemoe, Keith D, Castillo, Carlos Fernandez-del, Downes, Michael, Evans, Ronald M, Michaelson, James, Ferrone, Cristina R, Boucher, Yves, Jain, Rakesh K.
Publicado no Clin Cancer Res (2017)